Efficacy and safety results of a randomized, double-blind, vehicle-controlled phase 2 study of roflumilast foam 0.3% in patients with seborrheic dermatitis

被引：0
|
作者：
Zirwas, M. [1 ,2 ]
机构：
[1] Prob Med Res, Dermatologists Cent States, Bexley, OH USA
[2] Ohio Univ, Bexley, OH USA
[3] Arcutis Biotherapeut Inc, Westlake Village, CA USA
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
26
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study
    Worm, M.
    Bauer, A.
    Elsner, P.
    Mahler, V.
    Molin, S.
    Nielsen, T. S. S.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (05) : 1103 - 1110
  • [22] Clindamycin/benzoyl peroxide in the treatment of perioral dermatitis: A double-blind, randomized, vehicle-controlled study
    Draelos, Z
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB85 - AB85
  • [23] A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR™) in the management of atopic dermatitis in paediatric patients
    Patrizi, Annalisa
    Capitanio, Bruno
    Neri, Iria
    Giacomini, Federica
    Sinagra, Jo L.
    Raone, Beatrice
    Berardesca, Enzo
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2008, 19 (07) : 619 - 625
  • [24] Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: Results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials
    Feldman S.R.
    Matheson R.
    Bruce S.
    Grande K.
    Markowitz O.
    Kempers S.
    Brundage T.
    Wyres M.
    American Journal of Clinical Dermatology, 2012, 13 (4) : 261 - 271
  • [25] Efficacy and safety of topical delgocitinib (JTE-052), janus kinase inhibitor, in Japanese pediatric patients with atopic dermatitis: A phase II, randomized, double-blind, vehicle-controlled study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB53 - AB53
  • [26] Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea: A Randomized, Double-blind, Vehicle-Controlled Study
    Draelos, Zoe Diana
    Elewski, Boni
    Staedtler, Gerald
    Havlickova, Blanka
    CUTIS, 2013, 92 (06): : 306 - 317
  • [27] The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study
    Afshar, M.
    Kotol, P.
    Miller, J.
    Gallo, R.
    Hata, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (02) : 426 - 428
  • [28] Efficacy and Safety of Calcipotriene 0.005% Foam for the Treatment of Plaque-Type Psoriasis Results of Two Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Phase III Clinical Trials
    Feldman, Steven R.
    Matheson, Robert
    Bruce, Suzanne
    Grande, Kimberly
    Markowitz, Orit
    Kempers, Steven
    Brundage, Thomas
    Wyres, Melody
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2012, 13 (04) : 261 - 271
  • [29] A randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of topical diclofenac 3% gel for the treatment of rosacea
    Weiss, S
    Jangua, R
    Jacobson, C
    Kimball, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P26 - P26
  • [30] The Efficacy and Tolerability of Tazarotene Foam, 0.1%, in the Treatment of Acne Vulgaris in 2 Multicenter, Randomized, Vehicle-Controlled, Double-Blind Studies
    Feldman, Steven R.
    Werner, Cary P.
    Saenz, Alessandra B. Alio
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (04) : 438 - 446
12345